Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A
                    <i>post hoc</i>
                    analysis of the
                    <scp>SURPASS</scp>
                    ‐1 to ‐5 studies

Lingvay, Ildiko; YY. Cheng, Alice; A. Levine, Joshua; Gomez‐Valderas, Elisa; E. Allen, Sheryl; Ranta, Kari; Torcello‐Gómez, Amelia; T. Thieu, Vivian

doi:10.1111/dom.14943

Public

Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A <i>post hoc</i> analysis of the <scp>SURPASS</scp> ‐1 to ‐5 studies

Shared by NobleBlocks on Dec 27, 2022 • 12:00 AM UTC

Authors:

Ildiko Lingvay

Alice YY. Cheng

Joshua A. Levine

Abstract

Abstract Aim To assess composite endpoints combining glycaemic control (HbA1c < 7.0%, ≤ 6.5% or < 5.7%) with weight loss (≥ 5%, ≥ 10% or ≥ 15%) and without hypoglycaemia with tirzepatide in type 2 diabetes (T2D). Materials and Methods Data from the phase 3 SURPASS programme were evaluated post...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!